17/12/19 -"We have hiked our estimates on account of: 1. Faster than expected growth in the acquired Osiris business, which will result in a material uplift in the performance of the wound care business 2. ..."
Pages
51
Language
English
Published on
17/12/19
You may also be interested by these reports :
24/02/20
Sales missed expectations in Q3 due to the delay in installations of linacs in the US. Order intake was also weak with the US being the main drag. ...
21/02/20
Smith & Nephew reported good Q4/FY 19 numbers – trumping estimates. Q4/FY 19 sales were up 5.6%/4.4% on an underlying basis – driven by broad-based ...
20/02/20
We have not become more enthusiastic, but the inclusion of FMC’s better than expected performance has caused the increase in the EPS. The moderate ...
20/02/20
We have not become more enthusiastic, but the inclusion of the preliminary figures has caused the increase in the EPS. However, the quite colourless ...